Related Experiment Video
Updated: May 22, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Genetic Uncertainties Fueling Cholangiocarcinoma Progression
Sunil Kumar Kadiri1, Prashant Tiwari1
1Department of Pharmacology, College of Pharmaceutical Sciences, Dayananda Sagar University, Deverakeggahali, Kanakapura Road, Ramanagara Dist. Karnataka - 562112, India.
Genetic mutations in IDH1/2, FGFR2, and KRAS drive aggressive intrahepatic cholangiocarcinoma (iCCA) liver cancer. Understanding these genetic changes and epigenetic factors is key for developing targeted therapies for iCCA.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Intrahepatic cholangiocarcinoma (iCCA) is an aggressive liver cancer often diagnosed at late stages.
- Limited treatment options exist due to its complex etiology and late detection.
- Genomic research highlights the critical role of genetic alterations in iCCA development and progression.
Purpose of the Study:
- To investigate the genetic underpinnings of intrahepatic cholangiocarcinoma (iCCA) development and progression.
- To identify key mutations, gene expressions, and molecular pathways involved in iCCA tumorigenesis.
- To explore the impact of epigenetic modifications on iCCA aggressiveness.
Main Methods:
- Comprehensive genomic analysis of iCCA samples.
- Examination of specific gene mutations, including IDH1/2, FGFR2, and KRAS.
- Assessment of epigenetic alterations and their effect on gene expression.
Main Results:
- Identified frequent genetic abnormalities in iCCA, notably mutations in IDH1/2, FGFR2, and KRAS.
- These mutations disrupt normal cellular functions, promoting oncogenesis and malignant transformation.
- Epigenetic alterations were found to increase iCCA diversity and aggressiveness.
Conclusions:
- Genetic profiling is crucial for understanding iCCA molecular pathways.
- Identified mutations and pathways offer potential therapeutic targets for iCCA.
- A clear understanding of iCCA's genetic landscape can lead to personalized treatment strategies and improved patient outcomes.
More Related Videos
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer
Cancer Prevention
Some...